Data / Form D filings / SONALASENSE, INC.
SONALASENSE, INC.: Form D filings
SONALASENSE, INC., a biotechnology company in Oakland, CA, filed 4 Form D notices with the SEC between 2020 and 2023. The latest, on November 6, 2023, reports $9.8 million sold of a $15 million offering to 30 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1111 BROADWAY, SUITE 2040, Oakland, CA, 94607
- Phone
- (857) 222-4653
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- New York
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1825955
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2023 | New notice | $15,000,000 | $9,765,000 | $5,235,000 | 30 | Feb 21, 2023 | sec.gov |
| Jan 10, 2022 | New notice | $30,093,202 | $20,093,202 | $10,000,000 | 30 | Dec 29, 2021 | sec.gov |
| Feb 11, 2021 | New notice | $7,983,400 | $3,933,400 | $4,050,000 | 26 | Feb 1, 2021 | sec.gov |
| Sep 30, 2020 | New notice | $2,000,000 | $999,980 | $1,000,020 | 13 | Dec 9, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| MARK P. DE SOUZA | Executive Officer, Director | |
| STUART P. MARCUS | Executive Officer, Director | |
| VINCENT P. SAI | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Nov 6, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SONALASENSE, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.